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Reply 
We thank Lucertini and colleagues for their kind com-
ments concerning our article'! They make two main 
points. First, they confirm our findings that subfascial 
endoscopic perforator surgery is not required to correct 
thc greater proportion of incompetent perforating veins 
(IPVs) in limbs affected by superficial venous insufficiency 
alone. Second, they offer three possible explanations for 
the apparent failure of superficial surgery alone. 
We would like to make clear, however, that in our 
study the surgery performed did not involve specific 
attempts to avulse the IPVs. The perforators were not 
marked before surgery for the surgeon. We believe that 
some of the IPVs may have been partially or completely 
avulsed during phlebectomy. However, the greater pro-
portion of the changes noted in IPV physiology were, we 
believe, caused by the abolition of main stem reflux in the 
superficial system that allowed the IPV blood flow to 
return to normal. We therefore would argue that perfora-
tor physiology is to a large part dependent on the main 
stem venous hemodyamics. 
We would certainly agree with the final assertion that 
IPVs in the presence of deep disease require direct surgi-
cal correction with the subfascial endoscopic perforator 
technique. 
Wesley P. Stuart, MB, ehB, FReSE 
Andrew W. Bradbury, MD, FReSE 
Vascular Surgery Office 
University Department of Surgery 
Royal Infirmary 
Edinburgh, United Kingdom 
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Regarding "Endothelium-dependent vasodilatation is 
impaired in both microcirculation and 
macrocirculation during acute hyperglycemia" 
To the Editors: 
It was with great interest that I read the article by 
Akbari et al (J Vasc Surg 1998;28:687-94). However, I do 
not ibelieve that the results fully support the authors' con-
clusion that endothelial function is impaired after acute 
oral glucose loading in healthy subjects. 
Although there was an apparent decline in flow-medi-
ated dilatation of the brachial artery after glucose inges-
tion (4.2% vs 11.7%; P < .001), this decline appears to be 
largely related to the significant increase in the resting 
brachial artery diameter 60 minutes after the ingestion of 
the glucose (3.92 mm vs 3.73 mm; P< .02). In contrast, 
the brachial artery diameter after reactive hyperemia was 
not significantly different during fasting or hyperglycemia 
(4.22 vs 4.17 mm; P = .28). Although the absolute change 
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in the brachial artery diameter after reactive hyperemia is 
less after glucose ingestion, this is a result of the increased 
resting diameter. Thus, the decline in flow-mediated 
dilatation when expressed as a percentage of the resting 
diameter is likely explained by the increase in the resting 
diameter rather than by acute impairment of the nitric 
oxide pathway. Although the authors repeatedly discuss 
this increase in resting vessel diameter with hyperglycemia, 
they discount its significance. It has been shown repeated-
ly that flow-mediated vasodilatation is inversely related to 
the baseline brachial artery diameter.1·3 I suspect this is 
the explanation for their findings in the macrocirculation. 
The authors are correct in stating that there are diffi-
culties in assessing the microcirculation. Yet, they are confi-
dent that the iontophoresis of acetylcholine is likely the 
"most effective and reliable noninvasive method available" 
to assess this vascular bed. As previously stated, I am con-
cerned that the apparent difference noted in skin blood flow 
with hyperglycemia (when expressed as a percent change 
from baseline) is largely reflective of the significant increase 
in basal flux after glucose loading. In fact, the absolute 
change from baseline does not appear to be significantly dif-
ferent between fasting and hyperglycemia. Moreover, recent 
reports4,5 suggest that changes in skin blood flow in 
response to iontophoresis of acetylcholine are more likely 
mediated by prostanoids rather than by nitric oxide because 
NG-monomethyl-L-arginine (L-NMMA; an inhibitor of 
nitric oxide synthesis) infusion had no effect on the acetyl-
choline response. Because L-NMMA will most often atten-
uate the flow-mediated dilatation of the brachial artery, 
these two noninvasive assays may be examining different 
effects in the microcirculation versus the macrocirculation. 
Lawrence Title, MD 
Division of Cardiology 
New Halifax Infirmary 
Halifax, Nova Scotia, Canada 
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